Skip Nav Destination
Issues
1 February 2023
-
Cover Image
Cover Image
The cover image is adapted from Figure 2a and Figure 3 in the article, Prospective Cohort of Pre- and Post-diagnosis Diet with Survival Outcomes: An Alberta Endometrial Cancer Cohort Study, by Kokts-Porietis and colleagues. The prognostic relationship between diet and endometrial cancer survival remains largely unknown. The authors sought to determine pre- and post-diagnosis dietary composition, glycemic load (GL), inflammatory potential (Dietary Inflammatory Index (DII)) and quality (CanadianHealth Eating Index (C-HEI) 2005) associations with disease-free (DFS) and overall survival (OS) among endometrial cancer survivors. Additionally, they assessed associations between dietary changes with OS and explored obesity/physical activity effect modification. Figure 2a shows the Hazard Ratios (95% CI) for pre-diagnosis added sugar and disease-free survival. Figure 3 shows the Hazard Ratios (95% CI) for pre-diagnosis C-HEI 2005, glycemic load, total sugar and, added sugar by obesity and lifetime physical activity status with disease-free survival and overall survival in the Alberta Endometrial Cancer Cohort Study, 2002–2022. Results showed that adherence to higher quality dietary patterns were associated with better survival. The study provides novel evidence that both pre- and post-diagnosis diet are important prognostic factors for endometrial cancer survivors. Post-diagnosis survival associations with diet composition and quality highlight the potential for future interventions. For more information, see the article beginning on page 242. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Commentaries
Research Articles
Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study
Clare A. Aitken; Federica Inturrisi; Sylvia Kaljouw; Daan Nieboer; Albert G. Siebers; Willem J.G. Melchers; Adriaan J.C. van den Brule; Anco Molijn; John W.J. Hinrichs; Hubert G.M. Niesters; Folkert J. van Kemenade; Johannes Berkhof; Inge M.C.M. de Kok
Null Results in Brief
Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis
Yujia Lu; Yu Chen Zhao; Jenny Chang-Claude; Stephen B. Gruber; Andrea Gsur; Kenneth Offit; Ludmila Vodickova; Michael O. Woods; Long H. Nguyen; Kaitlin H. Wade; Robert Carreras-Torres; Victor Moreno; Daniel D. Buchanan; Michelle Cotterchio; Andrew T. Chan; Amanda I. Phipps; Ulrike Peters; Mingyang Song
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.